GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Interest Coverage

Diagnos (TSXV:ADK) Interest Coverage : 0 (At Loss) (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Diagnos's Operating Income for the three months ended in Mar. 2025 was C$-1.29 Mil. Diagnos's Interest Expense for the three months ended in Mar. 2025 was C$-0.15 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Diagnos's Interest Coverage or its related term are showing as below:


TSXV:ADK's Interest Coverage is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.09
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Diagnos Interest Coverage Historical Data

The historical data trend for Diagnos's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Diagnos Interest Coverage Chart

Diagnos Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diagnos Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diagnos's Interest Coverage

For the Health Information Services subindustry, Diagnos's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's Interest Coverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Diagnos's Interest Coverage falls into.


;
;

Diagnos Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diagnos's Interest Coverage for the fiscal year that ended in Mar. 2025 is calculated as

Here, for the fiscal year that ended in Mar. 2025, Diagnos's Interest Expense was C$-0.59 Mil. Its Operating Income was C$-3.81 Mil. And its Long-Term Debt & Capital Lease Obligation was C$0.29 Mil.

Diagnos did not have earnings to cover the interest expense.

Diagnos's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Diagnos's Interest Expense was C$-0.15 Mil. Its Operating Income was C$-1.29 Mil. And its Long-Term Debt & Capital Lease Obligation was C$0.29 Mil.

Diagnos did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Diagnos  (TSXV:ADK) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Diagnos Interest Coverage Related Terms

Thank you for viewing the detailed overview of Diagnos's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.
Executives
Tristram Coffin 10% Security Holder
Marc-andré Massue Senior Officer
Robert Dunn Director
Francis Bellido Director
Vincent Duhamel Director
André Larente Director, Senior Officer
Guillermo Moreno Robles Senior Officer
Georges Hébert Director
Gestion Maurice Pinsonnault Inc. 10% Security Holder

Diagnos Headlines

No Headlines